Want to see HK:3613 full AI Analyst Report?
Beijing Tong Ren Tang Chinese Medicine Co (3613) Stock Price & Analysis
3613 Stock Chart & Stats
- Day’s Range
- HKD 5.55 - HKD 5.68
- 52-Week Range
- HKD 5.40 - HKD 9.50
- Previous Close
- HKD 5.54
- Volume
- 566.00K
- Average Volume (3M)
- 1.05M
- Market Cap
- HKD 4.73B
- Enterprise Value
- HKD 3.52B
- Total Cash (Recent Filing)
- HKD 2.21B
- Total Debt (Recent Filing)
- HKD 125.80M
- Price to Earnings (P/E)
- 10.2
- Beta
- 0.45
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 12, 2026
- Dividend Yield
- 6.55%
Bulls Say, Bears Say
Bulls Say
High Profitability
The company’s high gross and net margins indicate substantial earnings capacity from its TCM portfolio and brand-led sales model. Strong profitability can support product investment, distribution development, and resilience over the next several quarters, provided margins remain defensible.
Conservative Balance Sheet
Minimal leverage gives the company considerable financial flexibility and reduces exposure to interest costs or refinancing pressure. A conservatively financed balance sheet can help preserve investment capacity, support dividends, and absorb operating volatility without relying heavily on new borrowing.
Strong TTM Cash Generation
Recent cash generation closely tracks reported earnings, indicating that TTM profitability is converting into substantial operating and free cash flow. This supports internally funded growth, shareholder distributions, and ongoing business needs without requiring significant external financing.
Bears Say
Uneven Revenue Growth
The recent rebound is encouraging, but declines in multiple annual periods show that top-line expansion has not been consistently steady. Uneven revenue performance can make channel planning and operating leverage less predictable, increasing reliance on continued recovery in demand.
Margin Normalization
Although current profitability remains strong, the lower net margin versus 2021–2022 indicates that earlier earnings economics have not been fully maintained. Continued normalization would reduce the amount of revenue converted into profit and could constrain future returns on growth investment.
Volatile Cash Conversion
The sharp cash-flow reversal followed by recovery suggests that cash conversion can vary materially between reporting periods, potentially because of working-capital timing or other operating movements. Such volatility makes liquidity planning and dependable funding of distributions or expansion more difficult.
Beijing Tong Ren Tang Chinese Medicine Co News
3613 FAQ
What was Beijing Tong Ren Tang Chinese Medicine Co’s price range in the past 12 months?
What is Beijing Tong Ren Tang Chinese Medicine Co’s market cap?
When is Beijing Tong Ren Tang Chinese Medicine Co’s upcoming earnings report date?
How were Beijing Tong Ren Tang Chinese Medicine Co’s earnings last quarter?
Is Beijing Tong Ren Tang Chinese Medicine Co overvalued?
Does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?
What is Beijing Tong Ren Tang Chinese Medicine Co’s EPS estimate?
How many shares outstanding does Beijing Tong Ren Tang Chinese Medicine Co have?
What happened to Beijing Tong Ren Tang Chinese Medicine Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Beijing Tong Ren Tang Chinese Medicine Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Wang Chi
- Employees
- 763
- Website
- cm.tongrentang.com
- Address
- HK
Beijing Tong Ren Tang Chinese Medicine Co (3613) Earnings & Revenues
3613 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 5 | 8 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 6 | 0 | 6 |








